Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 4/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | TNKS | O95271 | 1/20 | 0.63 |
| ▸ | MAOB | P27338 | 3/20 | 0.62 |
| ▸ | AR | P10275 | 1/20 | 0.55 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | NPY1R | P25929 | 1/20 | 0.54 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.54 |
| ▸ | RELA | Q04206 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26444784 | 0.87 | L3MBTL1 (0.58) | APPL3MBTL1TNKSMAOBAR | |
| SCHEMBL13475658 | 0.86 | MAOB (0.66) | APPL3MBTL1TNKSMAOBALOX5 | |
| SCHEMBL24368733 | 0.84 | MAOB (0.64) | APPL3MBTL1TNKSMAOBALOX5 | |
| SCHEMBL24368355 | 0.84 | MAOB (0.64) | APPL3MBTL1TNKSMAOBALOX5 | |
| SCHEMBL24368356 | 0.84 | MAOB (0.64) | APPL3MBTL1TNKSMAOBALOX5 | |
| SCHEMBL4659168 | 0.83 | MAOB (0.78) | MAOBALOX5CA1CA2CA9 | |
| SCHEMBL26255497 | 0.83 | MAOB (0.62) | APPL3MBTL1TNKSMAOBALOX5 | |
| SCHEMBL9132166 | 0.82 | MAOB (0.57) | APPL3MBTL1TNKSMAOBALOX5 | |
| SCHEMBL24368776 | 0.81 | MAOB (0.60) | APPTNKSMAOBARALOX5 | |
| SCHEMBL24369515 | 0.81 | MAOB (0.60) | APPL3MBTL1TNKSMAOBALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5468470-A | Radiation resistance and sunscreen agents | 3V INC. (US) | 1995-11-21 | — | — | US | claimed |
| EP-0613893-A1 | Benzofuran derivatives and the use thereof as stabilizers against UV radiations | 3V SIGMA S.p.A (IT) | 1994-09-07 | — | — | EP | claimed |
| US-20230140749-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | LG CHEM, LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
| US-20230140749-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | LG CHEM, LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
| US-5468470-A | Radiation resistance and sunscreen agents | 3V INC. (US) | 1995-11-21 | — | — | US | disclosed |
| US-5362481-A | Useful in cosmetics and dermatology | 3V INC. (US) | 1994-11-08 | — | — | US | disclosed |
| EP-0613893-A1 | Benzofuran derivatives and the use thereof as stabilizers against UV radiations | 3V SIGMA S.p.A (IT) | 1994-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230140749-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | ARL1, LAS1L, AR | APP 2315/4885L3MBTL1 12/4885TNKS 2692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.